| Nine Months Results of Strides Pharma Science (in Rs. Cr.) |
Dec '19 |
Dec '18 |
Dec '17 |
Dec '16 |
Dec '15 |
|
| Net Sales/Income from operations |
1,232.41 |
1,102.88 |
1,026.38 |
1,522.48 |
1,433.80 |
|
| Other Operating Income |
-- |
-- |
-- |
88.59 |
99.66 |
|
| Total Income From Operations |
1,232.41 |
1,102.88 |
1,026.38 |
1,611.07 |
1,533.46 |
|
| EXPENDITURE |
|
|
|
|
|
|
| Consumption of Raw Materials |
654.08 |
674.88 |
566.95 |
708.59 |
838.84 |
|
| Purchase of Traded Goods |
26.51 |
16.45 |
34.15 |
84.78 |
51.66 |
|
| Increase/Decrease in Stocks |
4.11 |
-34.63 |
29.41 |
-22.98 |
-9.74 |
|
| Power & Fuel |
-- |
-- |
-- |
-- |
-- |
|
| Employees Cost |
158.38 |
174.32 |
183.59 |
299.45 |
199.55 |
|
| Depreciation |
68.48 |
61.49 |
60.44 |
92.95 |
75.61 |
|
| Excise Duty |
-- |
-- |
-- |
-- |
-- |
|
| Admin. And Selling Expenses |
-- |
-- |
-- |
-- |
-- |
|
| R & D Expenses |
-- |
-- |
-- |
-- |
-- |
|
| Provisions And Contingencies |
-- |
-- |
-- |
-- |
-- |
|
| Exp. Capitalised |
-- |
-- |
-- |
-- |
-- |
|
| Other Expenses |
241.27 |
210.65 |
201.64 |
345.77 |
280.77 |
|
| P/L Before Other Inc. , Int., Excpt. Items & Tax |
79.58 |
-0.28 |
-49.80 |
102.51 |
96.77 |
|
| Other Income |
72.90 |
58.20 |
139.36 |
118.86 |
130.81 |
|
| P/L Before Int., Excpt. Items & Tax |
152.48 |
57.92 |
89.56 |
221.37 |
227.57 |
|
| Interest |
48.39 |
37.78 |
70.53 |
85.76 |
68.25 |
|
| P/L Before Exceptional Items & Tax |
104.09 |
20.14 |
19.03 |
135.61 |
159.33 |
|
| Exceptional Items |
-- |
-2.01 |
22.43 |
-92.57 |
-24.08 |
|
| P/L Before Tax |
104.09 |
18.13 |
41.46 |
43.04 |
135.24 |
|
| Tax |
18.76 |
2.54 |
-24.26 |
9.66 |
33.81 |
|
| P/L After Tax from Ordinary Activities |
85.33 |
15.59 |
65.72 |
33.38 |
101.43 |
|
| Prior Year Adjustments |
-- |
-- |
-- |
-- |
-- |
|
| Extra Ordinary Items |
-- |
-4.04 |
60.02 |
-- |
-- |
|
| Net Profit/(Loss) For the Period |
85.33 |
11.55 |
125.74 |
33.38 |
101.43 |
|
| Equity Share Capital |
89.55 |
89.55 |
89.50 |
89.37 |
89.27 |
|
| Reserves Excluding Revaluation Reserves |
-- |
-- |
-- |
-- |
-- |
|
| Equity Dividend Rate (%) |
-- |
-- |
-- |
-- |
-- |
|
| EPS Before Extra Ordinary |
|
|
|
|
|
|
| Basic EPS |
9.53 |
1.29 |
7.35 |
3.74 |
12.62 |
|
| Diluted EPS |
9.53 |
1.29 |
7.34 |
3.73 |
12.53 |
|
| EPS After Extra Ordinary |
|
|
|
|
|
|
| Basic EPS. |
9.53 |
1.29 |
7.35 |
3.74 |
12.62 |
|
| Diluted EPS. |
9.53 |
1.29 |
7.34 |
3.73 |
12.53 |
|
| Public Share Holding |
|
|
|
|
|
|
| No Of Shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
| Share Holding (%) |
-- |
-- |
-- |
-- |
-- |
|
| Promoters and Promoter Group Shareholding |
|
|
|
|
|
|
| a) Pledged/Encumbered |
|
|
|
|
|
|
| - Number of shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
-- |
-- |
|
| b) Non-encumbered |
|
|
|
|
|
|
| - Number of shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
-- |
-- |
|
Source : Dion Global Solutions Limited
